These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16796358)

  • 1. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
    Rawas-Qalaji MM; Simons FE; Simons KJ
    AAPS PharmSciTech; 2006 Apr; 7(2):E41. PubMed ID: 16796358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.
    Rawas-Qalaji MM; Simons FE; Simons KJ
    Drug Dev Ind Pharm; 2007 May; 33(5):523-30. PubMed ID: 17520443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
    Rawas-Qalaji MM; Simons FE; Simons KJ
    Biopharm Drug Dispos; 2006 Dec; 27(9):427-35. PubMed ID: 17009337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.
    Rachid O; Rawas-Qalaji M; Simons FE; Simons KJ
    Eur J Pharm Biopharm; 2012 Nov; 82(3):598-604. PubMed ID: 22683694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S; Fukai T; Sakamoto T
    AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets.
    Bafail R; Rawas-Qalaji M; Rawas-Qalaji M; Aodah A
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1617-1623. PubMed ID: 31353966
    [No Abstract]   [Full Text] [Related]  

  • 8. Formulation and Evaluation of Fast-Disintegrating Sublingual Tablets of Atropine Sulfate: the Effect of Tablet Dimensions and Drug Load on Tablet Characteristics.
    Aodah A; Bafail RS; Rawas-Qalaji M
    AAPS PharmSciTech; 2017 Jul; 18(5):1624-1633. PubMed ID: 27650282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
    AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
    Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
    Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T; Kurano T; Kanazawa T; Suzuki N
    Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tablet formulation of an active pharmaceutical ingredient with a sticking and filming problem: direct compression and dry granulation evaluations.
    Bejugam NK; Mutyam SK; Shankar GN
    Drug Dev Ind Pharm; 2015 Feb; 41(2):333-41. PubMed ID: 24279424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D; Bhandari A; Gaur PK; Yasir M; Kumar SS; Choudhary D; Saxena PK
    Curr Clin Pharmacol; 2018; 13(2):128-135. PubMed ID: 29521214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the API properties on the ODTs manufacturing from co-processed excipient systems.
    Krupa A; Jachowicz R; Pędzich Z; Wodnicka K
    AAPS PharmSciTech; 2012 Dec; 13(4):1120-9. PubMed ID: 22941425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.